Oramed Pharmaceuticals
ORMP
#9127
Rank
S$0.14 B
Marketcap
S$3.66
Share price
1.42%
Change (1 day)
10.66%
Change (1 year)

Oramed Pharmaceuticals (ORMP) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$23.3 Million

According to Oramed Pharmaceuticals's latest financial reports the company's total liabilities are S$23.3 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Oramed Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$13.49 M-82.27%
2023-12-31S$76.14 M441.69%
2022-12-31S$14.05 M
2021-08-31S$15.42 M-3.51%
2020-08-31S$15.99 M-24.53%
2019-08-31S$21.18 M-5.22%
2018-08-31S$22.35 M-15.33%
2017-08-31S$26.4 M16.52%
2016-08-31S$22.66 M953.25%
2015-08-31S$2.15 M70.7%
2014-08-31S$1.26 M86.88%
2013-08-31S$0.67 M-64.54%
2012-08-31S$1.9 M162.53%
2011-08-31S$0.72 M-13.83%
2010-08-31S$0.84 M12.88%
2009-08-31S$0.74 M-42.8%
2008-08-31S$1.3 M-39.97%
2007-08-31S$2.16 M126.47%
2006-08-31S$0.95 M1140.4%
2005-08-31S$0.07 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ultragenyx Pharmaceutical
RARE
S$1.50 B 6,365.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
S$69.07 B 296,322.40%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
S$84.71 B 363,425.30%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
S$69.3 M 197.41%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
S$0.11 B 372.21%๐Ÿ‡บ๐Ÿ‡ธ USA